[-] Show simple item record

dc.contributor.authorRufner, K. Lorraineeng
dc.contributor.authorPark, Michael K.eng
dc.contributor.authorTweed, Elizabeth M.eng
dc.date.issued2010-07eng
dc.description.abstractAspirin probably shouldn't be used for routine prevention because of its potential risks (strength of recommendation [SOR]: B, systematic review of inconsistent evidence). However, aspirin is likely to be effective for secondary prevention of colorectal adenomas (SOR: A, systematic review).eng
dc.identifier.citationJournal of Family Practice, 59(7) 2010: 410c-410d.eng
dc.identifier.urihttp://hdl.handle.net/10355/7908eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2010 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectcolorectal carcinomaseng
dc.subjectcolorectal adenomaseng
dc.subject.lcshColon (Anatomy) -- Cancer -- Preventioneng
dc.subject.lcshAspirin -- Therapeutic useeng
dc.subject.lcshAspirin -- Health aspectseng
dc.titleIs aspirin effective for primary prevention of colon cancer?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record